Related by context. Frequent words. (Click for all words.) 67 recurrent glioblastoma 67 gastrointestinal stromal tumors GIST 65 intravenously administered 64 superficial bladder cancer 64 relapsed multiple myeloma 64 relapsing multiple sclerosis 63 relapsed refractory multiple myeloma 63 Dasatinib 63 Amrubicin 63 biologic therapy 63 Irinotecan 63 liposomal formulation 63 Mipomersen 62 subcutaneous formulation 62 Proxinium TM 62 Traficet EN 62 post herpetic neuralgia PHN 62 phase IIb clinical 62 ulcerative colitis UC 62 painful diabetic neuropathy 62 secondary hyperparathyroidism 62 Tacrolimus 62 Adalimumab 62 forodesine 62 metastatic hormone refractory 62 mTOR inhibitor 62 double blinded placebo 62 luteinizing hormone releasing 62 Pivotal Phase III 62 RRMS patients 62 placebo controlled clinical 61 Golimumab 61 Losartan 61 administered subcutaneously 61 oropharyngeal candidiasis 61 pertuzumab 61 chronic angina 61 Dapagliflozin 61 MKC# 61 Cytoxan 61 diabetic neuropathic pain 61 interferon beta 1b 61 active comparator 61 multiple myeloma MM 61 ThermoDox R 61 Tesetaxel 61 Phase Ib II 61 intravesical 61 rilonacept 61 APTIVUS 61 pegylated interferon alpha 61 Pirfenidone 61 octreotide 61 voriconazole 60 clopidogrel Plavix 60 intravenous immunoglobulin 60 aprepitant 60 chlorambucil 60 label multicenter 60 Laquinimod 60 Phase IIIb 60 heparin induced thrombocytopenia 60 intra arterial 60 Aliskiren 60 mRCC 60 tigecycline 60 leukemia CLL 60 sunitinib malate 60 acute promyelocytic leukemia APL 60 pheochromocytoma 60 proteasome inhibitor 60 oral candidiasis 60 postherpetic neuralgia PHN 60 hepatitis C HCV 60 goserelin 60 Metastatic Melanoma 60 pancreatic neuroendocrine tumors 60 mycophenolate mofetil 60 Clevudine 60 relapsed refractory 60 randomized multicenter 60 DDP# 59 Factor VIIa 59 irbesartan 59 Natalizumab 59 primary hypercholesterolemia 59 Eltrombopag 59 Daclizumab 59 Pivotal Trial 59 decitabine 59 lupus nephritis 59 R sorafenib tablets 59 oral anticoagulant 59 fumarate 59 gastrointestinal stromal tumors 59 leukemia ALL 59 glatiramer acetate 59 phase IIa clinical 59 fluvastatin 59 pseudobulbar affect PBA 59 methylnaltrexone